* Legal terms of this website: This website is not a business or charity entity. We are not liable or responsible for our partners or the content you find regarding their websites or products advertised by their website. Our website is informative and a tool for awareness. We do not endorse any products, activities or messages on their website.

Articles for submission: We welcome Submissions for print on this website . Got an interesting story ? All submitted articles of an informative nature will be scrutinized before publication.  DISCLAIMER: We do not endorse any advertising or products of a 3rd party.    Contact email for submissions:   martha.harlam@icloud.com

Ataxia Clinical Training – National Ataxia Foundation

Intensive in-person program designed to provide practical knowledge about the diagnostic investigation and treatment of the Ataxias.

In Navarra , Spain the clinic for movement disorders at the hospital treat patients with the disorders of Ataxia, Parkinson’s, tremors and more.

Using EMS treatment- electrical devices are advancing the treatment process of these disorders. Under the medical supervision of the movement unit EMS electro suits can enhance muscle control and rehabilitation.

Larimar’s Friedreich’s Ataxia Drug Seeks FDA Approval

Larimar advances first Friedreich’s ataxia drug toward accelerated FDA approval with novel surrogate endpoint.

Novo Nordisk Vs. Eli Lilly: Cheap Vs. Expensive

The companies Novo Nordisk and Eli Lilly are producing products that tackle diabetes, weight loss and obesity This article addresses these areas and lets you develop an informed opinion about both of these their benefits and development. The diseases associated with Ataxia have all these traits. Here is an opportunity to help invest in diseases that affect Ataxia.

Hope For People With Spinocerebellar Ataxia

Intrabio to conduct phase III trial in SCA6 and Episodic Ataxia Type-2 – Ataxia UK

Friedreich’s Ataxia News

Friedreich’s Ataxia News – Community, Research & Resources…

Quirónsalud

Information on the causes, symptoms, and treatment of ataxia, a condition that causes motor incoordination affecting the entire body.

CIRM approves over $160M to support preclinical and clinical research, advances education opportunities and access to clinical trials – CIRM

Mito Light helps Spinocerebellar Ataxia

Hello Martha,

Thank you for your message and for bringing up such an important topic. I understand you are asking about using MITO LIGHT if someone has Spinocerebellar Ataxia.

To answer your question, MITO LIGHT is a non-medical wellness device that uses red and near-infrared light. While we cannot make medical claims or give medical advice regarding specific conditions like Spinocerebellar Ataxia, many people use red light therapy as part of their overall well-being routine. Research into how light therapy affects the nervous system is still ongoing, and it’s always best to consult your neurologist before starting, especially when it comes to possible interactions with medications or sensitivity to light.

That said, red, and especially near-infrared light, is widely known for its positive effects on pain relief and tissue support. These wavelengths help with the regeneration of strained muscles and connective tissues, reduce inflammation, and increase collagen production. Since collagen is a key component of connective tissue, this can be beneficial for overall mobility and comfort. Red and near-infrared light also improves blood circulation, which means more nutrients are delivered to the tissues where they are needed for repair and regeneration.

If you are thinking of trying red light therapy as a gentle part of your routine, I would recommend starting with short sessions (5-10 minutes per illuminated area) at a comfortable distance (40-50 cm from the device). Always listen to your body, keep your eyes closed if you are light-sensitive (or use eye protection), and stop if anything feels uncomfortable.

If it helps, I can share the exact wavelengths, irradiance and technical details of the specific MITO LIGHT model you are looking at so your doctor can review them.

If there is anything else we can do to help, please do not hesitate to contact us.

New NeuroArts Blueprint Analysis Finds Strong Return on Investment from Music Engagement

What is the Brief Ataxia Rating Scale (BARS)? – National Ataxia Foundation

News and events from the Arts+Mind Lab

The Ataxia world market growth has been a trendsetter for the Phama and biotechnology companies.

The development of patient growth worldwide has influenced the development. The USA market is the biggest followed by Europe, Asian Pacific and the Middle East and Africa markets.

Awareness of the disease has attributed to the rise in market value. Our research gives you insight into the Ataxia market.

A Gene-Edited Cell Therapy for an Incurable Disease

Researchers Receive USD 4.8M Grant to Treat Friedreich’s Ataxia.

Zapping the brain to help ataxia

Source: National Ataxia Foundation

Brain chips for ataxia

IGTP

The development of a gene therapy for Friedreich’s ataxia receives €2.17 million in new public funding…